Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Central Coast Health Watch  >  Current Article
Premium Content

Amgen profit tops analysts’ estimates on drug sales, tax credit

By   /   Friday, January 30th, 2015  /   Comments Off on Amgen profit tops analysts’ estimates on drug sales, tax credit

Amgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.

    Print       Email
Amgen, the nation’s biggest biotech company, reported fourth-quarter profits that beat analysts’ estimates, aided by a tax benefit and higher-than-estimated sales of arthritis drug Enbrel.

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email